Neuren initiates manufacture of NNZ-2591 for Phase 2 trials
Released
Latest announcements
Ask a question
Your question will be sent privately to Neuren Pharmaceuticals Limited. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Neuren Pharmaceuticals Limited a question about this announcement.